Works matching IS 03407004 AND DT 2006 AND VI 55 AND IP 10

Results: 14

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1294, doi. 10.1007/s00262-005-0102-x

By:

Wobser, Marion;
Keikavoussi, Petra;
Kunzmann, Volker;
Weininger, Markus;
Andersen, Mads H.;
Becker, Juergen C.

Publication type:

Article

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1238, doi. 10.1007/s00262-005-0104-8

By:

Pilon-Thomas, Shari;
Verhaegen, Monique;
Kuhn, Lisa;
Riker, Adam;
Mulé, James J.

Publication type:

Article

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1209, doi. 10.1007/s00262-005-0106-6

By:

Fay, Joseph W.;
Palucka, A. Karolina;
Paczesny, Sophie;
Dhodapkar, Madhav;
Johnston, Dennis A.;
Burkeholder, Susan;
Ueno, Hideki;
Banchereau, Jacques

Publication type:

Article

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1258, doi. 10.1007/s00262-005-0111-9

By:

Yunfei Gao;
Dongqing Zhang;
Buxiang Sun;
Hajime Fujii;
Kosuna, Ken-Ichi;
Zhinan Yin

Publication type:

Article

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1267, doi. 10.1007/s00262-005-0114-6

By:

Zhengrong Cui;
Fu Qiu

Publication type:

Article

Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1219, doi. 10.1007/s00262-005-0112-8

By:

Uhi Toh;
Fujii, Teruhiko;
Seki, Naoko;
Niiya, Fumihiko;
Shirouzu, Kazuo;
Yamana, Hideaki

Publication type:

Article

Telomere length of in vivo expanded CD4+CD25+ regulatory T-cells is preserved in cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1198, doi. 10.1007/s00262-005-0107-5

By:

Wolf, Dominik;
Rumpold, Holger;
Koppelstätter, Christian;
Gastl, Guenther A.;
Steurer, Michael;
Mayer, Gert;
Gunsilius, Eberhard;
Tilg, Herbert;
Wolf, Anna M.

Publication type:

Article

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1285, doi. 10.1007/s00262-005-0116-4

By:

Prell, Rodney A.;
Gearin, Lisa;
Simmons, Andrew;
VanRoey, Melinda;
Jooss, Karin

Publication type:

Article

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1280, doi. 10.1007/s00262-006-0121-2

By:

Knudsen, Anette;
Monstad, Sissel E.;
Dørum, Anne;
Lønning, Per E.;
Salvesen, Helga B.;
Drivsholm, Lars;
Aarseth, Jan H.;
Vedeler, Christian A.

Publication type:

Article

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1228, doi. 10.1007/s00262-006-0122-1

By:

Falkensammer, Claudia;
Jöhrer, Karin;
Gander, Hubert;
Ramoner, Reinhold;
Putz, Thomas;
Rahm, Andrea;
Greil, Richard;
Bartsch, Georg;
Thurnher, Martin

Publication type:

Article

The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1247, doi. 10.1007/s00262-005-0108-4

By:

Skopeliti, Margarita;
Voutsas, Ioannis F.;
Klimentzou, Persefoni;
Tsiatas, Marinos L.;
Beck, Alexander;
Bamias, Aristotelis;
Moraki, Maria;
Livaniou, Evangelia;
Neagu, Monica;
Voelter, Wolfgang;
Tsitsilonis, Ourania E.

Publication type:

Article

Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1185, doi. 10.1007/s00262-005-0118-2

By:

Harlin, Helena;
Kuna, Todd V.;
Peterson, Amy C.;
Meng, Yuru;
Gajewski, Thomas F.

Publication type:

Article

Epigenetic regulation of immune escape genes in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1159, doi. 10.1007/s00262-006-0164-4

By:

Tomasi, Thomas B.;
Magner, William J.;
Khan, A. Nazmul H.

Publication type:

Article

ACKNOWLEDGEMENT TO REVIEWERS.

Published in:: Cancer Immunology, Immunotherapy, 2006, v. 55, n. 10, p. 1299, doi. 10.1007/s00262-006-0137-7
Publication type:: Article

Works matching IS 03407004 AND DT 2006 AND VI 55 AND IP 10

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34<sup>+</sup> progenitor-derived dendritic cells.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model.

Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion.

Telomere length of in vivo expanded CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells is preserved in cancer patients.

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.

Tumor progression despite massive influx of activated CD8<sup>+</sup> T cells in a patient with malignant melanoma ascites.

Epigenetic regulation of immune escape genes in cancer.

ACKNOWLEDGEMENT TO REVIEWERS.